Follow the people · Insider
Karen Krasney
Karen Krasney files insider transactions with the SEC as an evp, general counsel of Capricor Therapeutics (CAPR). We hold 5 disclosed purchases and sales filed since 22 January 2015, 3 of them in the last 90 days.
- Files forCAPR
- Disclosed buys and sells5 in all, 3 in the last 90 days
- Last disclosure29 June 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 21 January 2015 — 25 June 2026EVP, General Counsel · Capricor Therapeutics (CAPR)60 Form 4 lines · source: SEC Form 4
Everything they disclosed
60 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 24,100 shares of Capricor TherapeuticsSEC Form 429 June 2026Common Stock · traded 25 June 2026 · filed 29 June 2026
- ▼ sold on the open market 24,100 shares of Capricor TherapeuticsSEC Form 429 June 2026Common Stock · traded 25 June 2026 · filed 29 June 2026
- exercised options over 24,100 shares of Capricor Therapeutics (a derivative holding)SEC Form 429 June 2026Stock Option (Right to Buy) · traded 25 June 2026 · filed 29 June 2026
- exercised options over 500 shares of Capricor TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 500 shares of Capricor TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- exercised options over 400 shares of Capricor TherapeuticsSEC Form 424 June 2026Common Stock · traded 24 June 2026 · filed 24 June 2026
- ▼ sold on the open market 400 shares of Capricor TherapeuticsSEC Form 424 June 2026Common Stock · traded 24 June 2026 · filed 24 June 2026
- exercised options over 500 shares of Capricor Therapeutics (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 22 June 2026 · filed 24 June 2026
- exercised options over 400 shares of Capricor Therapeutics (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 24 June 2026 · filed 24 June 2026
- exercised options over 25,000 shares of Capricor TherapeuticsSEC Form 44 May 2026Common Stock · traded 1 May 2026 · filed 4 May 2026
- ▼ sold on the open market 25,000 shares of Capricor TherapeuticsSEC Form 44 May 2026Common Stock · traded 1 May 2026 · filed 4 May 2026
- exercised options over 25,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 44 May 2026Stock Option (Right to Buy) · traded 1 May 2026 · filed 4 May 2026
- exercised options over 693 shares of Capricor TherapeuticsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- exercised options over 21,488 shares of Capricor TherapeuticsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- exercised options over 2,819 shares of Capricor TherapeuticsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- ▼ sold on the open market 25,000 shares of Capricor TherapeuticsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- exercised options over 693 shares of Capricor Therapeutics (a derivative holding)SEC Form 41 April 2026Stock Option (Right to Buy) · traded 31 March 2026 · filed 1 April 2026
- exercised options over 21,488 shares of Capricor Therapeutics (a derivative holding)SEC Form 41 April 2026Stock Option (Right to Buy) · traded 31 March 2026 · filed 1 April 2026
- exercised options over 2,819 shares of Capricor Therapeutics (a derivative holding)SEC Form 41 April 2026Stock Option (Right to Buy) · traded 31 March 2026 · filed 1 April 2026
- exercised options over 2,500 shares of Capricor TherapeuticsSEC Form 427 March 2026Common Stock · traded 30 December 2025 · filed 27 March 2026
- exercised options over 2,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 427 March 2026Stock Option (Right to Buy) · traded 30 December 2025 · filed 27 March 2026
- exercised options over 2,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 427 March 2026Stock Option (Right to Buy) · traded 30 December 2025 · filed 27 March 2026
- exercised options over 2,500 shares of Capricor TherapeuticsSEC Form 427 March 2026Common Stock · traded 30 December 2025 · filed 27 March 2026
- was granted 22,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 5 January 2026 · filed 7 January 2026
- was granted 22,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 5 January 2026 · filed 7 January 2026
- was granted 22,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 5 January 2026 · filed 7 January 2026
- was granted 22,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 5 January 2026 · filed 7 January 2026
- was granted 60,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 46 January 2025Stock Option (Right to Buy) · traded 2 January 2025 · filed 6 January 2025
- exercised options over 3,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 416 December 2024Stock Option (Right to Buy) · traded 13 December 2024 · filed 16 December 2024
- exercised options over 5,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 416 December 2024Stock Option (Right to Buy) · traded 13 December 2024 · filed 16 December 2024
- exercised options over 8,000 shares of Capricor TherapeuticsSEC Form 416 December 2024Common Stock · traded 13 December 2024 · filed 16 December 2024
- was granted 80,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 44 January 2024Stock Option (Right to Buy) · traded 2 January 2024 · filed 4 January 2024
- was granted 7,140 shares of Capricor Therapeutics (a derivative holding)SEC Form 44 January 2024Stock Option (Right to Buy) · traded 2 January 2024 · filed 4 January 2024
- was granted 80,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 45 January 2023Stock Option (Right to Buy) · traded 3 January 2023 · filed 5 January 2023
- was granted 11,878 shares of Capricor Therapeutics (a derivative holding)SEC Form 45 January 2023Stock Option (Right to Buy) · traded 3 January 2023 · filed 5 January 2023
- exercised options over 18,932 shares of Capricor Therapeutics (a derivative holding)SEC Form 44 November 2022Stock Option (Right to Buy) · traded 3 November 2022 · filed 4 November 2022
- exercised options over 18,932 shares of Capricor TherapeuticsSEC Form 44 November 2022Common Stock · traded 3 November 2022 · filed 4 November 2022
- was granted 84,080 shares of Capricor Therapeutics (a derivative holding)SEC Form 44 January 2022Stock Option (Right to Buy) · traded 3 January 2022 · filed 4 January 2022
- was granted 95,693 shares of Capricor Therapeutics (a derivative holding)SEC Form 46 January 2021Stock Option (Right to Buy) · traded 4 January 2021 · filed 6 January 2021
- was granted 104,908 shares of Capricor Therapeutics (a derivative holding)SEC Form 49 June 2020Stock Option (Right to Buy) · traded 5 June 2020 · filed 9 June 2020
- was granted 14,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- was granted 3,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- was granted 2,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- was granted 5,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- was granted 3,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- was granted 18,932 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- returned to the issuer 14,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- returned to the issuer 3,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- returned to the issuer 2,500 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- returned to the issuer 5,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- returned to the issuer 3,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- returned to the issuer 18,932 shares of Capricor Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option (Right to Buy) · traded 12 February 2020 · filed 14 February 2020
- was granted 14,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 49 August 2019Stock Option (right to buy) · traded 8 August 2019 · filed 9 August 2019
- was granted 35,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 44 January 2018Stock Option (right to buy) · traded 2 January 2018 · filed 4 January 2018
- was granted 25,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 44 January 2017Stock Option (right to buy) · traded 3 January 2017 · filed 4 January 2017
- was granted 50,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 46 June 2016Stock Option (right to buy) · traded 2 June 2016 · filed 6 June 2016
- ▲ bought on the open market 4,060 shares of Capricor TherapeuticsSEC Form 418 March 2016Common Stock · traded 16 March 2016 · filed 18 March 2016
- ▲ bought on the open market 2,030 shares of Capricor Therapeutics (a derivative holding)SEC Form 418 March 2016Warrants (Right to Buy) · traded 16 March 2016 · filed 18 March 2016
- was granted 30,000 shares of Capricor Therapeutics (a derivative holding)SEC Form 45 March 2015Stock Option (right to buy) · traded 3 March 2015 · filed 5 March 2015
- ▲ bought on the open market 7,096 shares of Capricor TherapeuticsSEC Form 422 January 2015Common Stock · traded 21 January 2015 · filed 22 January 2015
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.